Sekar Kathiresan

11PUBLICATIONS
111CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Forensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 21, 2025
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids.

Ulf Landmesser, Thomas Thum, Lale Tokgözoğlu

|Jun 01, 2023
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing.

Reindert F Oostveen, Amit V Khera, Sekar Kathiresan

|May 15, 2023
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.

Lisa N Kasiewicz, Souvik Biswas, Aaron Beach

|Dec 06, 2022
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Krishna G Aragam, Tao Jiang, Anuj Goel

|Oct 31, 2022
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models.

Richard G Lee, Anne Marie Mazzola, Maurine C Braun

|Oct 10, 2022
Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease.

Amit V Khera, Minxian Wang, Mark Chaffin

Pageof 2

Frequent Collaborators

5 joint publications

Amit V Khera

3 joint publications

Adam S Butterworth

3 joint publications

Mark Chaffin

3 joint publications

Minxian Wang